BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Liu HL, Peng H, Huang CH, Zhou HY, Ge J. Mutational separation and clinical outcomes of TP53 and CDH1 in gastric cancer. World J Gastrointest Surg 2023; 15(12): 2855-2865 [PMID: 38222005 DOI: 10.4240/wjgs.v15.i12.2855]
URL: https://www.wjgnet.com/1948-9366/full/v15/i12/2855.htm
Number Citing Articles
1
Hong-Qiao Cai, Li-Yue Zhang, Li-Ming Fu, Bin Xu, Yan Jiao. Mutational landscape of TP53 and CDH1 in gastric cancer. World Journal of Gastrointestinal Surgery 2024; 16(2): 276-283 doi: 10.4240/wjgs.v16.i2.276
2
Yang Jin, Xiaobo He, Yanfeng Wu. Gastrointestinal cancer: molecular pathogenesis and targeted therapy. Molecular Biomedicine 2025; 6(1) doi: 10.1186/s43556-025-00361-9
3
Cao Zhang, Jun Wen, Zijian Liu, Ruyi Li, Yaqin He, Suraiya Saleem. YTHDF3 Promoted Gastric Cancer Progression by Facilitating m6A‐Dependent Degradation of APC mRNA. Analytical Cellular Pathology 2026; 2026(1) doi: 10.1155/ancp/5045743
4
Fang Li, Huiyan Deng, Zeqing Hu, Zihao Chen, Huirui Zhang, Jiankun He, Xiaoxiao Wang, Yueping Liu. Immunohistochemical‐Based Molecular Typing of ACRG Combined With Immune‐Associated PD‐L1 Expression Can Predict the Prognosis of Gastric Cancer. Cancer Medicine 2025; 14(7) doi: 10.1002/cam4.70863